Catalyst Pharmaceuticals Stock Options Expiring on 17th of January 2025
| CPRX Stock | USD 22.11 0.37 1.70% |
Catalyst Pharmaceuticals' latest option contracts expiring on 2025-01-17 are carrying combined implied volatility of 0.06 with a put-to-call open interest ratio of 0.0 over 8 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2025-01-17. The total put volume is at 1.0, with calls trading at the volume of 1.0. This yields a 0.03 put-to-call volume ratio.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Catalyst Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. Catalyst Pharmaceuticals In The Money Call Balance
When Catalyst Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Catalyst Pharmaceuticals stock is said to be in the money. When it comes to buying Catalyst Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Catalyst Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Catalyst Current Options Market Mood
Catalyst Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Catalyst Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Catalyst Pharmaceuticals' options investors are not very successful. Catalyst Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Catalyst contract
Base on the Rule 16, the options market is currently suggesting that Catalyst Pharmaceuticals will have an average daily up or down price movement of about 0.003544% per day over the life of the 2025-01-17 option contract. With Catalyst Pharmaceuticals trading at USD 22.11, that is roughly USD 7.84E-4. If you think that the market is fully incorporating Catalyst Pharmaceuticals' daily price movement you should consider buying Catalyst Pharmaceuticals options at the current volatility level of 0.0567%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Catalyst |
Catalyst Pharmaceuticals Option Chain
When Catalyst Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Catalyst Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Catalyst Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Catalyst. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Catalyst. It also shows strike prices and maturity days for a Catalyst Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | CPRX Option Call 17-01-2025 12 | 0 | 2025-01-17 | 0.0 - 0.0 | 8.65 | In |
Call | CPRX Option Call 17-01-2025 17 | 0 | 2025-01-17 | 0.0 - 0.0 | 4.2 | In |
Call | CPRX Option Call 17-01-2025 20 | 0 | 2025-01-17 | 0.0 - 0.0 | 2.4 | In |
Call | CPRX Option Call 17-01-2025 22 | 0 | 2025-01-17 | 0.0 - 0.0 | 1.05 | |
Call | CPRX Option Call 17-01-2025 25 | 0 | 2025-01-17 | 0.0 - 0.0 | 0.2 | |
Call | CPRX Option Call 17-01-2025 30 | 0 | 2025-01-17 | 0.0 - 0.0 | 0.08 | |
Put | CPRX Option Put 17-01-2025 20 | 0 | 2025-01-17 | 0.0 - 0.0 | 0.27 | |
Put | CPRX Option Put 17-01-2025 22 | 0 | 2025-01-17 | 0.0 - 0.0 | 1.3 | In |
Catalyst Pharmaceuticals Market Cap Over Time
Market Cap |
| Timeline |
Catalyst Total Stockholder Equity
Total Stockholder Equity |
|
Catalyst Pharmaceuticals Corporate Management
| Philip Schwartz | Co Sec | Profile | |
| CMA CPA | VP, Officer | Profile | |
| Pete Sr | Vice Sales | Profile | |
| Mary Coleman | VP Relations | Profile | |
| Stanley MD | Senior Discovery | Profile | |
| Gary MD | Chief Officer | Profile |
Additional Tools for Catalyst Stock Analysis
When running Catalyst Pharmaceuticals' price analysis, check to measure Catalyst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalyst Pharmaceuticals is operating at the current time. Most of Catalyst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Catalyst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalyst Pharmaceuticals' price. Additionally, you may evaluate how the addition of Catalyst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.